Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α

• Asıl Yazarlar: Jieru Han (Yazar), Wenhao Li (Yazar), Guangyu Shi (Yazar), Yunlei Huang (Yazar), Xutao Sun (Yazar), Na Sun (Yazar), Deyou Jiang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hindawi Limited, 2022-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Ulcerative colitis (UC) is a complex inflammatory bowel disease (IBD) associated with mitochondrial function. Atractylenolide III (AT III) is a natural product with anti-inflammatory effects. The aim of this work is to investigate the protective effect of AT III on UC and its underlying mechanisms....